Investor Presentation - First Six Months of 2021
130
Investor presentation First six months of 2021
Novo NordiskⓇ
Providing access to affordable care for vulnerable patients in
every country
Finding solutions to improve care for vulnerable patients in every country
requires a multi-faceted approach and actions
Identifying vulnerable
populations globally
Map vulnerable patient based on:
。 Minority, migrant or displaced
populations
。 Low socioeconomic status or
limited resources
o Underserved populations
Analysis completed in 21 affiliates in
2020 and by end-2021 in 2/3 of affiliates
Implementation of action plan to be
•
done within a year of analysis
completion
⚫
.
ONCD
The NCO antip
Affordable human insulin in low- &
middle-income countries
As of 1 August 2020, ceiling price reduced to 3 USD per
human insulin vial in 76 low and middle income countries
Access to Insulin Commitment is promise of low-cost
human insulin, reaching est. 3.2 million in 2020 and avg.
price of 2.9 USD/vial
Expanding Changing Diabetes® in Children programme
No child should die from type 1 diabetes with the ambition
to reach 100,000 children by 2030
MITE
Partnerships are essential to
reach vulnerable patients
GENEVE
ICRC
+
iii
In 2020, 28,296 children were reached across 14 countries
and in 2021 Ghana was added as the 15th country
DANISH
RED
CROSS
Donations to World
Diabetes Foundation
and Novo Nordisk
Haemophilia
Foundation
Chronic Care in
Humanitarian Crises
Note: Changing Diabetes in Children is a public-private partnership between the International Society for Pediatric and Adolescent Diabetes, the World Diabetes Foundation, Roche and Novo Nordisk.View entire presentation